EUVIMEDEUVIMED entdecken
Crossref

COVID-19 in the post-vaccination era: Who is at risk of severe disease?

Alonso-Bello Cesar Daniel, Pérez-Barragán Edgar, Moncayo-Coello Carol Vivian, Rojo-Gutiérrez María Isabel

Journal of Allergy & Infectious Diseases · 2023

DOI: 10.46439/allergy.5.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy & Infectious Diseases, 2023. Verfasst von Alonso-Bello Cesar Daniel und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaccination against SARS-CoV-2 began in December 2020 and with this strategy, the course of the pandemic would be modified. BNT162b2 (Pfizer–BioNTech), mRNA-1273 (Moderna), and ChAdOx1 nCoV-19 (Oxford–AstraZeneca) were the main vaccines that demonstrated a reduction in hospitalization and death from SARS-CoV-2 in clinical trials. Post-vaccination infection by COVID-19 is called breakthrough infection. Breakthrough infection is more frequent in health workers, and smokers, and critical illness is more frequent in patients with advanced age, and cardiovascular disease. Following vaccination efforts around the world, the incidence of severe COVID-19 infection has decreased, declaring the end of the pandemic by the World Health Organization. However, efforts to keep vaccination active, especially in at-risk populations, must continue.

Zitieren

APA

Daniel, A. C., Edgar, P., Vivian, M. C., & Isabel, R. M. (2023). COVID-19 in the post-vaccination era: Who is at risk of severe disease?. Journal of Allergy & Infectious Diseases. https://doi.org/10.46439/allergy.5.040

Vancouver

Daniel AC, Edgar P, Vivian MC, Isabel RM. COVID-19 in the post-vaccination era: Who is at risk of severe disease?. Journal of Allergy & Infectious Diseases. 2023. doi:10.46439/allergy.5.040

BibTeX
@article{Daniel2023,
  author = {Daniel, Alonso-Bello Cesar and Edgar, Pérez-Barragán and Vivian, Moncayo-Coello Carol and Isabel, Rojo-Gutiérrez María},
  title = {COVID-19 in the post-vaccination era: Who is at risk of severe disease?},
  journal = {Journal of Allergy & Infectious Diseases},
  year = {2023},
  doi = {10.46439/allergy.5.040}
}
Kostenlos starten →